Expertise in
7
conditions

Dr. Marc Rothenberg

Pediatrics
Cincinnati Children's Hospital Medical Center
3333 Burnet Ave, 
Cincinnati, OH 
Clinical Trials:Currently Recruiting for 1 Trial
Expertise in
7
conditions
Cincinnati Children's Hospital Medical Center
3333 Burnet Ave, 
Cincinnati, OH 

Overview

Marc Rothenberg is a Pediatrics provider practicing medicine in Cincinnati, Ohio.

Dr. Rothenberg is highly rated in 7 conditions, according to our data. His clinical expertise encompasses Eosinophilic Esophagitis, Eosinophilic Enteropathy, Eosinophilic Colitis, Endoscopy, and Tissue Biopsy.

He is actively involved in clinical research, co-authoring 352 peer reviewed articles and participating in 8 clinical trials.

Specialties

Pediatrics

Licenses

Allergy & Immunology in OH

Languages Spoken

English

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

CareSource
  • HMO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medical Health
  • HMO
  • PPO

Locations

Cincinnati Children's Hospital Medical Center
3333 Burnet Ave, Cincinnati, OH 45229

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

8 Clinical Trials

A Prospective, Multicenter Study to Compare and Validate Endoscopic, Histologic, Molecular, and Patient-Reported Outcomes in Pediatric and Adult Patients With Eosinophilic Esophagitis (EoE), Gastritis (EoG), Enteritis (EoN) and Colitis (EoC)
A Prospective, Multicenter Study to Compare and Validate Endoscopic, Histologic, Molecular, and Patient-Reported Outcomes in Pediatric and Adult Patients With Eosinophilic Esophagitis (EoE), Gastritis (EoG), Enteritis (EoN) and Colitis (EoC)
Enrollment Status: Recruiting
Publish Date: September 12, 2025
A Phase 3, 52-week, Open-label, Single Arm Study to Investigate the Efficacy and Safety of Mepolizumab SC in Participants Aged 6 to 17 Years With Hypereosinophilic Syndrome
A Phase 3, 52-week, Open-label, Single Arm Study to Investigate the Efficacy and Safety of Mepolizumab SC in Participants Aged 6 to 17 Years With Hypereosinophilic Syndrome
Enrollment Status: Completed
Publish Date: December 04, 2025
Intervention Type: Drug
Study Drug: Mepolizumab
Study Phase: Phase 3
A Randomized, Double-blind, Placebo-controlled Clinical Trial to Evaluate the Efficacy of Dupilumab (Anti-IL4a) in Subjects With Eosinophilic Gastritis
A Randomized, Double-blind, Placebo-controlled Clinical Trial to Evaluate the Efficacy of Dupilumab (Anti-IL4a) in Subjects With Eosinophilic Gastritis
Enrollment Status: Completed
Publish Date: November 04, 2025
Intervention Type: Drug
Study Drug: Dupilumab
Study Phase: Phase 2
A Phase 2, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacodynamic Effect of AK002 in Patients With Eosinophilic Gastritis and/or Eosinophilic Gastroenteritis
A Phase 2, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacodynamic Effect of AK002 in Patients With Eosinophilic Gastritis and/or Eosinophilic Gastroenteritis
Enrollment Status: Completed
Publish Date: January 19, 2024
Intervention Type: Other, Drug
Study Phase: Phase 2
A Randomized, Double-Blind, Placebo-controlled Clinical Trial to Evaluate the Efficacy of Benralizumab (Anti-IL5RA) in Subjects With Eosinophilic Gastritis
A Randomized, Double-Blind, Placebo-controlled Clinical Trial to Evaluate the Efficacy of Benralizumab (Anti-IL5RA) in Subjects With Eosinophilic Gastritis
Enrollment Status: Completed
Publish Date: February 03, 2022
Intervention Type: Biological
Study Drug: Benralizumab
Study Phase: Phase 2/Phase 3
Demographics, Clinical Characteristics, and Pathology of Eosinophilic Gastritis, Enteritis, and Colitis in a Multi-Site Cohort
Demographics, Clinical Characteristics, and Pathology of Eosinophilic Gastritis, Enteritis, and Colitis in a Multi-Site Cohort
Enrollment Status: Completed
Publish Date: September 28, 2021
A Multi-centre, Open-label Extension, Safety Study to Describe the Long-term Clinical Experience of Mepolizumab in Participants With Hypereosinophilic Syndrome (HES) From Study 200622
A Multi-centre, Open-label Extension, Safety Study to Describe the Long-term Clinical Experience of Mepolizumab in Participants With Hypereosinophilic Syndrome (HES) From Study 200622
Enrollment Status: Completed
Publish Date: June 23, 2020
Intervention Type: Drug
Study Phase: Phase 3
Six Food vs One Food Eosinophilic Esophagitis Elimination Diet (SOFEED) Followed by Swallowed Glucocorticoid Trial
Six Food vs One Food Eosinophilic Esophagitis Elimination Diet (SOFEED) Followed by Swallowed Glucocorticoid Trial
Enrollment Status: Completed
Publish Date: May 26, 2020
Intervention Type: Other, Drug
Study Phase: Phase 2/Phase 3
View 7 Less Clinical Trials

352 Total Publications

Esophageal epithelial cell-state transitions underlie the severity of pediatric eosinophilic esophagitis.
Esophageal epithelial cell-state transitions underlie the severity of pediatric eosinophilic esophagitis.
Journal: bioRxiv : the preprint server for biology
Published: April 10, 2026
Similar Doctors
Expertise in
16
conditions
Dr. Rebecca Marsh
Pediatrics
Expertise in
16
conditions
Dr. Rebecca Marsh
Pediatrics

Cincinnati Children's Hospital Medical Center

3333 Burnet Ave, 
Cincinnati, OH 
 (0.1 miles away)
513-636-4266
Languages Spoken:
English
See accepted insurances

Rebecca Marsh is a Pediatrics provider practicing medicine in Cincinnati, Ohio. Dr. Marsh is highly rated in 16 conditions, according to our data. Her clinical expertise encompasses Hemophagocytic Lymphohistiocytosis, Non-Langerhans-Cell Histiocytosis, Histiocytosis, Reticulohistiocytoma, and Bone Marrow Transplant.

Expertise in
57
conditions
Dr. Donald Gilbert
Pediatrics
Expertise in
57
conditions
Dr. Donald Gilbert
Pediatrics

Cincinnati Children's Hospital Medical Center

3333 Burnet Ave, 
Cincinnati, OH 
 (0.1 miles away)
513-636-4222
Languages Spoken:
English
See accepted insurances

Donald Gilbert is a Pediatrics provider practicing medicine in Cincinnati, Ohio. Dr. Gilbert is highly rated in 57 conditions, according to our data. His clinical expertise encompasses Tourette Syndrome, Transient Tic Disorder, Drug Induced Dyskinesia, Movement Disorders, and Deep Brain Stimulation.

Expertise in
160
conditions
Dr. David Neal
Pediatrics
Expertise in
160
conditions
Dr. David Neal
Pediatrics

Office

9560 Children Dr Ste A, 
Mason, OH 
 (17.6 miles away)
513-636-6800
Languages Spoken:
English
See accepted insurances
Offers Telehealth

David Neal is a Pediatrics provider practicing medicine in Mason, Ohio. Dr. Neal is highly rated in 160 conditions, according to our data. His clinical expertise encompasses Tuberous Sclerosis Complex, Tuberous Sclerosis, Cortical Dysplasia, and Seizures.

Frequently Asked Questions about Dr. Marc Rothenberg

How do I make an appointment with Dr. Marc Rothenberg?

You can book an appointment with Dr. Marc Rothenberg by calling their office at 513-636-6771. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Marc Rothenberg a top-rated expert for Eosinophilic Esophagitis?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Marc Rothenberg is classified as an Elite expert for Eosinophilic Esophagitis, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Marc Rothenberg specialize in?

While Dr. Marc Rothenberg is a Pediatrics, they have specific expertise in Eosinophilic Esophagitis, Eosinophilic Enteropathy, and Eosinophilic Colitis. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Pediatrics.

Does Dr. Marc Rothenberg participate in research or clinical trials?

Yes. Dr. Marc Rothenberg has published 352 articles and abstracts on conditions like Eosinophilic Esophagitis. You can view a list of Dr. Marc Rothenberg's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Marc Rothenberg accept my insurance?

Dr. Marc Rothenberg accepts most major insurance plans, including CareSource and Humana. We recommend calling the office directly at 513-636-6771 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Rothenberg's expertise for a condition
ConditionClose
View All 13 Experienced Conditions
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile